- Home
- MREO vs SPXX Comparison
MREO vs SPXX Comparison
Compare MREO & SPXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MREO | SPXX |
|---|---|---|
| Founded | 2015 | 2004 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 324.6M | 314.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MREO | SPXX |
|---|---|---|
| Price | $0.46 | $17.69 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $3.90 | N/A |
| AVG Volume (30 Days) | ★ 21.9M | 51.3K |
| Earning Date | 11-10-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.55% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $500,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6,363.05 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.20 | $13.57 |
| 52 Week High | $3.26 | $16.05 |
Technical Indicators
Market Signals| Indicator | MREO | SPXX |
|---|---|---|
| Relative Strength Index (RSI) | 31.93 | 42.50 |
| Support Level | $0.42 | $17.91 |
| Resistance Level | $0.78 | $18.14 |
| Average True Range (ATR) | 0.08 | 0.19 |
| MACD | 0.04 | -0.05 |
| Stochastic Oscillator | 10.72 | 15.70 |
Price Performance
Historical ComparisonAbout MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About SPXX Nuveen S&P 500 Dynamic Overwrite Fund
Nuveen S&P 500 Dynamic Overwrite Fund is a diversified closed-end management investment company. Its investment objective is to seek attractive total returns with less volatility than the S&P 500 Index by investing in a U.S. equity portfolio that seeks to substantially replicate the price movements of the S&P 500 Index, as well as selling call options on approximately 35%-75% of the notional value of the Fund's equity portfolio in an effort to enhance the Fund's risk-adjusted returns.